D-Mannose-Modified M2 Macrophage Membrane-Derived Decoy Nanovesicles for Synergistic Immunotherapy of Asthma
ACS Nano · 13.01.2026 · 20 (1) · 208-224
DOI: 10.1021/acsnano.5c04996 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 24.12.2025. Verfasst von Shukun Zhao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Clinical Research Center for Respirator…. Hauptthemen laut MEDLINE: Asthma, Mannose, Macrophages, Immunotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science and Technology Foundation of Shenzhen City, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Clinical Research Center for Respiratory Disease, Shenzhen Institute of Respiratory Diseases, Shenzhen People…
- Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China.
- Medical laboratory center, Shenzhen Luohu People's Hospital, The Third Affiliated Hospital (The Affiliated Luohu Hospital) of Shenzhen University, Shenzhen University, Shenzhen 518052, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
- National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510…
ORCID-Profile: Lang Rao, Junxia Zheng, Shanze Chen
Förderung
- National Key Research and Development Program of China
- Science and Technology Foundation of Shenzhen City
- National Natural Science Foundation of China
- Shenzhen University
- Shenzhen Medical Research Fund
- Shenzhen Medical Key Discipline Construction
- Shenzhen Clinical Research Center for Respiratory Diseases
- Shenzhen Key Laboratory of Respiratory Diseases
Zitieren
APA
Zhao, S., Jiang, Q., Yu, L., Liu, Q., Chen, Z., Zhan, D., Chen, S., Yang, Y., Zhong, J., Guo, B., Shi, F., Chen, R., Wang, L., Rao, L., Zheng, J., Meng, Q. F., & Chen, S. (2026). D-Mannose-Modified M2 Macrophage Membrane-Derived Decoy Nanovesicles for Synergistic Immunotherapy of Asthma. ACS Nano, 20(1), 208-224. https://doi.org/10.1021/acsnano.5c04996
Vancouver
Zhao S, Jiang Q, Yu L, Liu Q, Chen Z, Zhan D, et al. D-Mannose-Modified M2 Macrophage Membrane-Derived Decoy Nanovesicles for Synergistic Immunotherapy of Asthma. ACS Nano. 2026;20(1):208-224. doi:10.1021/acsnano.5c04996
BibTeX
@article{Zhao2026,
author = {Zhao, Shukun and Jiang, Qiong and Yu, Ling and Liu, Quan and Chen, Zi and Zhan, Danting and Chen, Shuyu and Yang, Yuqiong and Zhong, Jiacheng and Guo, Bingxin and Shi, Fei and Chen, Rongchang and Wang, Lingwei and Rao, Lang and Zheng, Junxia and Meng, Qian-Fang and Chen, Shanze},
title = {D-Mannose-Modified M2 Macrophage Membrane-Derived Decoy Nanovesicles for Synergistic Immunotherapy of Asthma},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {1},
pages = {208--224},
doi = {10.1021/acsnano.5c04996}
}
EUVIMED